HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology39147 papers

Atrial fibrillation

Last edited: 4/23/2026

Overview

Atrial fibrillation (AF) is a common arrhythmia affecting approximately 37.6 million people worldwide, characterized by irregular and often rapid heart rate, increasing risks of stroke, heart failure, and mortality 8 58.

Diagnosis

Electrocardiogram (ECG) showing irregularly irregular rhythm 8.

Monitoring for paroxysmal episodes using Holter or event monitors 8.

Echocardiography to assess left atrial size and function 22 42.

Blood tests for markers of inflammation and cardiac injury 12 28.

Management

First-line treatments:

- Oral anticoagulation (e.g., NOACs, warfarin) to prevent stroke 6 7 11 31 41. - Rate control with beta-blockers, calcium channel blockers, or digoxin 9 59.

Rhythm control:

- Antiarrhythmic drugs (e.g., amiodarone) for cardioversion and maintenance of sinus rhythm 10 44. - Catheter ablation, including pulmonary vein isolation (PVI) using radiofrequency, cryoablation, or pulsed field ablation 3 4 29 50 65.

Lifestyle modifications:

- Caffeine consumption may reduce recurrence 8 9 10. - Lifestyle interventions under nurse-led management can reduce repeat ablations 11.

Special Populations

Elderly:

- Integrated care management focusing on multimorbid conditions improves outcomes 22. - Anticoagulation strategies tailored to bleeding risk are crucial 47.

Comorbidities:

- Diabetes management impacts AF outcomes; consider glycemic control 61. - Obesity influences AF progression and management strategies 63.

Pregnancy:

- Management focuses on balancing anticoagulation risks with maternal and fetal safety 5 57.

Key Recommendations

Use oral anticoagulants (NOACs preferred) to prevent stroke in AF patients, especially those at high risk 6 7 41 (Evidence: Strong).

Consider catheter ablation for recurrent AF refractory to medication, with pulsed field ablation showing promising outcomes 3 4 29 (Evidence: Moderate).

Implement lifestyle interventions, including potentially continued caffeine consumption, to reduce AF recurrence 8 9 10 (Evidence: Moderate).

Tailor anticoagulation strategies in elderly patients considering polypharmacy and bleeding risk 47 (Evidence: Moderate).

Integrate comprehensive care addressing multiple comorbidities in elderly AF patients 22 (Evidence: Expert opinion).

References

Showing 100 most recent of 9581 indexed papers.

1 Roozbehi K, Semirani-Nezhad D, Soleimani H, Soltani P, Saeidi S, Farahvash Y et al.. Postoperative Atrial Fibrillation in Patients Undergoing Non-Cardiac Surgery. The American journal of cardiology 2026. link 2 Arevalo E, Erazo C, Serpa F, Rivera A, Kewcharoen J, Bhardwaj R et al.. Prognostic Impact of Early Recurrence Following Pulsed Field Ablation: A Meta-Analysis. Journal of cardiovascular electrophysiology 2026. link 3 Prajapati P, Vemulapalli HS, Rodriguez-Riascos JF, Muthu P, Srivathsan K. Evaluating Pulsed Field Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Procedural Outcomes. Pacing and clinical electrophysiology : PACE 2026. link 4 Barbosa GS, Katsuyama ES, Fukunaga CK, Fernandes JM, Coan ACC, Palatianos Y et al.. Surgical ablation in non-mitral valve cardiac surgeries: a meta-analysis of early outcomes. Heart (British Cardiac Society) 2026. link 5 Abdalla AME, Durga KP, Chukka A, Kotte M, Awais M, Perveen A et al.. Comparative Outcomes of ICE Versus TEE/Fluoroscopy Guidance Transseptal Puncture in LA Procedures: A Systematic Review and Meta-Analysis. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2026. link 6 Providencia R, Ali H, Barra S, Creta A, Kukendrarajah K, Kanagaratnam P et al.. Ablation of atrial fibrillation and risk of stroke: A meta-analysis. Heart rhythm 2026. link 7 Samaras A, Karakasis P, Feidakis A, Giannakoulas G, Fragakis N, Nielsen-Kudsk JE et al.. Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis. European heart journal. Cardiovascular pharmacotherapy 2026. link 8 Wong CX, Cheung CC, Montenegro G, Oo HH, Peña IJ, Tang JJ et al.. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial. JAMA 2026. link 9 Rosenberg K. Less recurrent atrial fibrillation with coffee consumption versus abstinence. The American journal of nursing 2026. link 10 Agarwal A, Ezekowitz J. After cardioversion in AF, continued caffeinated coffee consumption vs. abstinence reduced AF or atrial flutter recurrence at 6 mo. Annals of internal medicine 2026. link 11 Papakonstantinou PE, Lip GYH. In symptomatic AF, nurse-led pre-ablation lifestyle treatment reduced repeat ablations or cardioversions at 1 y. Annals of internal medicine 2026. link 12 Khider D, Neuilly O, Hiram R. Pro- and Anti-Inflammatory Cytokines' Implication in Right Heart Disease, Arrhythmogenesis, and Atrial Fibrillation. Biomolecules 2026. link 13 Kaba RA, Rajkumar C, Mattace-Raso F. Guideline commentary on the ESC/EACTS 2024 guidelines for atrial fibrillation: a focus on managing AF in the older population. Age and ageing 2026. link 14 Wolfes J, Colla CA, Frommeyer G, Ellermann C, Eckardt L. AF-CARE in the Elderly: Implications of the 2024 ESC Guideline on the Management of Atrial Fibrillation in Older Patients. Gerontology 2026. link 15 Atzema CL, Cox JL, Cheung CC, Coll-Vinent B, Benjamin EJ, Jackevicius CA et al.. Comparing Guidelines for Atrial Fibrillation: Focus on Emergency Medicine. Annals of emergency medicine 2026. link 16 Maher L, McCarthy R, Helmi L, Byrne L, Kelly B, Walsh K. Pulmonary Vein Isolation: Patient Experience under Conscious Sedation versus Anaesthesia. Irish medical journal 2026. link 17 Van der Graaf M, Abeln BGS, Van Dijk VF, Liebregts M, Wijffels MCEF, Balt JC et al.. Circular over-the-wire pulsed field ablation for atrial fibrillation: differences in outcomes between conscious sedation or general anesthesia. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2026. link 18 Jain H, Passey S, Jain J, Soni K, Pushparaji B, Ahmed R et al.. Conscious Sedation Versus General Anesthesia for Percutaneous Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 19 Biasin M, Lomi S, Pagani L, Noacco Y, Bonadiman L, Betta D et al.. Safety of cardiologist-only propofol sedation for elective electrical cardioversion: a retrospective observational study. Journal of cardiovascular medicine (Hagerstown, Md.) 2026. link 20 D'Andria Ursoleo J, Bottussi A, Agosta VT, Barucco G, Ripoll JG, Cinotti R et al.. Remimazolam Besylate Versus Propofol for Procedural Sedation in Patients Undergoing Electrical Cardioversion: A Prospective, Noninferiority Cohort Study. Journal of cardiothoracic and vascular anesthesia 2026. link 21 Du M, Ye L, Zhang Q, Yao X, Mi J, Li L et al.. Current status and associated factors of intraoperative pain during radiofrequency catheter ablation for atrial fibrillation under conscious sedation: single-center experience. BMC cardiovascular disorders 2026. link 22 Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G et al.. Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trial. American heart journal 2026. link 23 Kiuru N, Reinilä S, Langén V, Jaakkola J, Airaksinen KEJ, Halminen O et al.. Trends in Polypharmacy Among Patients With Atrial Fibrillation: A Report From the Finnish AntiCoagulation in Atrial Fibrillation Nationwide Cohort Study. Journal of the American Heart Association 2026. link 24 Hardi H, Barinda AJ, Vidya AP, Utama KE, Mahata LE. Corticosteroid Use and Atrial Fibrillation: Exploring Underlying Mechanisms, FAERS Disproportionality Analysis, and a Meta-Analysis of Clinical Studies. Cardiovascular toxicology 2026. link 25 Tan S, Zhang Z, Lin Q, Tu T, Zhu J, Zeng G et al.. Burden and age-specific trends of atrial fibrillation/atrial flutter from 1990 to 2023: a growing challenge among younger and middle-aged adults. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2026. link 26 Monteiro SM, Bota P, Cunha PS, Oliveira MM, Laranjo S, da Silva HP. Machine learning for the prediction of atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis. Computer methods and programs in biomedicine 2026. link 27 Pais P. Non-inferiority clinical trials: What they are and when they should be done. The National medical journal of India 2026. link 28 Yano M, Egami Y, Kise M, Mukai T, Kobayashi N, Sugino A et al.. Inflammation and myocardial injury after pulmonary vein isolation with distinct pulsed field ablation modalities: Comparison with thermal ablation. International journal of cardiology 2026. link 29 Ad N, Romano MA, Bolling S, Zhou Z, McCarthy P, Malaisrie C et al.. The ICE-AFIB trial: A multicenter prospective investigational device exemption (IDE) trial using cryosurgical ablation for atrial fibrillation during concomitant cardiac surgery. The Journal of thoracic and cardiovascular surgery 2026. link 30 Krányák D, Novák A, Pataky N, Sághy L, Vámos M, Szili-Török T et al.. Utility of Pharmacologic Conversion of Persistent Atrial Fibrillation by Amiodarone as a Predictor of Outcome After Pulmonary Vein Isolation. Journal of cardiovascular electrophysiology 2026. link 31 Ismaili D, Im J, Schnabel RB, Eschenhagen T, Christ T. Sex differences in human atrial electrophysiology: the dark side of the moon? Will engineered heart tissue help to bring light into the darkness?. Naunyn-Schmiedeberg's archives of pharmacology 2026. link 32 Mohanty S, Torlapati PG, Casella M, La Fazia VM, Valeri Y, Gianni C et al.. Management of oral anticoagulation after pulsed field ablation for atrial fibrillation: Insights from a multicenter study. Heart rhythm 2026. link 33 Trevisan C, Ravelli A, Rivera-Caravaca JM, Zanforlini BM, Sergi G, Dan GA et al.. Quality of life, care needs and priorities in atrial fibrillation: the impact of number and patterns of comorbidities. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2026. link 34 Lee JJ, Daoud EG, Simon JW, Aasbo JD, Tomassoni GF. Simultaneous Leadless Pacemaker Implant With Atrioventricular Node Ablation via Internal Jugular Approach. Pacing and clinical electrophysiology : PACE 2026. link 35 Cacciapuoti F. Epicardial Adipose Tissue as a Cardiometabolic Target in Atrial Fibrillation: Implications for Ablation Strategies and Emerging Metabolic Therapies. Medical sciences (Basel, Switzerland) 2026. link 36 Guilleminot P, Richard C, Roger A, Daller M, Laurent G, Vergely C et al.. Incidence and Predictors of Hypoattenuated Thickening and Device-Related Thrombus at Three Months Postprocedural CT Assessment Following Left Atrial Appendage Occlusion With Amplatzer Devices-A Single-Center Cohort. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 37 Tanner H, Dernektsi C, Neugebauer F, Goulouti E, Lam A, Elchinova E et al.. Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland. BMJ open 2026. link 38 Mondragon RR, Vendrov AE, Lozhkin A, Jimenez Vazquez EN, Wang S, Hayami T et al.. Mitochondrial NOX4 drives atrial fibrillation via redox-dependent structural remodeling and fibrosis. Free radical biology & medicine 2026. link 39 Maeda J, Furutani M, Miyauchi S, Nakashima M, Ishibashi N, Sakai T et al.. RNA sequence analysis of differentially expressed genes in left atrial appendage thrombus. Journal of thrombosis and thrombolysis 2026. link 40 Nozoe M, Mannoji H, Ikenaga T, Yamamoto S, Miyake R, Ishikita A et al.. ICE-Guided Cavotricuspid Isthmus Ablation Using a Circular Multielectrode Pulsed-Field Catheter: Stepwise Strategy. Pacing and clinical electrophysiology : PACE 2026. link 41 Harrington J, Reddy RK, Carnicelli A, Wilson L, Lopes RD, Gersh BJ et al.. Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation. American heart journal 2026. link 42 Kabutoya T, Makimoto H, Anno K, Kurosu YT, Kimura Y, Okuyama T et al.. Prolonged P-wave duration is associated with increased left atrial volume and delayed atrial conduction assessed by electro-anatomic mapping in patients with atrial fibrillation. Journal of electrocardiology 2026. link 43 Olsen FJ, Diederichsen SZ, Jørgensen PG, Jensen MT, Dahl A, Landler NE et al.. Effects of Atrial Fibrillation Screening According to Echocardiographic Measures of Cardiac Structure and Function: A Post Hoc Analysis of the LOOP Randomized Clinical Trial. Journal of the American Heart Association 2026. link 44 Ku D, Lim HE, Park J, Kim S, Kim DK, Kim DI et al.. Risk factors of failed electrical cardioversion in patients with persistent or long-standing persistent atrial fibrillation. Acta cardiologica 2026. link 45 Deisenhofer I, Seitz J, Lotteau S, Albenque JP, Busch S, Nguyen-Tu MS et al.. Targetable atrial tachycardias after artificial intelligence-guided ablation of persistent atrial fibrillation. Heart rhythm 2026. link 46 Sommer P, Castellano S, Ahapov K, Jansen MM, Mehta NK, Kong MH. A single-center trial of electrographic flow mapping and concomitant voltage mapping in sinus rhythm and atrial fibrillation (FLOW EVAL-AF). Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2026. link 47 Liu H, Bucci T, Lam SHM, Chen Y, Zhao M, Romiti GF et al.. Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry. Heart rhythm 2026. link 48 Rankinen J, Hernesniemi J, Tynkkynen JT. Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications. Heart (British Cardiac Society) 2026. link 49 Zhang Z, Luo Y, Zou Q, Mo Z. N6-methyladenosine modification of NEU1 mediated by METTL3 exacerbates angiotensin II-induced atrial fibrillation. Cell adhesion & migration 2026. link 50 Cobarro L, Negreira-Caamaño M, Gómez-Burgueño L, López-Alacid I, Ramos-Jiménez J, Marco Del Castillo Á et al.. Wide-Antral pulmonary vein isolation in patients undergoing atrial fibrillation ablation with a Single-Shot technique: rationale and design of the WIDER-PVI trial. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2026. link 51 Szeplaki G, Fitzpatrick N, Laurilla K, Dudurych I, Sommerijns E, Komleva A et al.. Initial Clinical Experience With a Novel 4D Intracardiac Echocardiographic Imaging and Guidance System in Catheter Ablation Procedures. Journal of cardiovascular electrophysiology 2026. link 52 Robledo-Nolasco R, Andrade-Cuellar EN, Solis-Gómez JC, Guillot-Castillo SY, Zamora-Diaz JJIY, Aceves-Millan R et al.. Atrial myopathy in persistent atrial fibrillation: Three-dimensional quantification of atrial fibrosis by high-density electro-anatomic mapping and its association with arrhythmia duration. Current problems in cardiology 2026. link 53 Tang SC, Lin SY, Chen CH, Liu YB, Ho LT, Kuo CH et al.. Real-World Edoxaban Concentrations in Older Patients Receiving Reduced-Dose Regimens. Clinical pharmacology and therapeutics 2026. link 54 Liao R, Zhang L, Knops P, Ye Z, Taverne YJHJ, Kluin J et al.. Mapping the unseen: Programmed electrical stimulation to detect concealed conduction block. Heart rhythm 2026. link 55 Suri RS, McIntyre WF, Belley-Cote EP, Fournier RN, Um KJ, Farkhondehpay N et al.. Anteroposterior vs Anterolateral Shock Vectors for Atrial Fibrillation Cardioversion: Design and Rationale of the SHOCK-VECTOR Trial. The Canadian journal of cardiology 2026. link 56 Rothe M, Boehmer AA, Schneider KY, Spork P, Wiedenmann LC, Nussbaum E et al.. Questioning the role of pulmonary vein isolation in multimorbid patients: A prospective analysis in more than 1400 AF patients. Heart rhythm 2026. link 57 Qiao CY, Xu Y, Jiang R, Zhang M, Huang BJ, Ding L. Determinants of quality of life in older adults with atrial fibrillation: a structural equation modeling analysis. Frontiers in public health 2026. link 58 Lane DA, Andrade JG, Arbelo E, Boriani G, Hendriks JM, Lee SR et al.. Atrial fibrillation. Lancet (London, England) 2026. link02166-X) 59 Abouzid MR, Nwaukwa C. Optimal Timing and Duration of Beta-Blocker Therapy for Preventing Postoperative Atrial Fibrillation: A Literature Review. Cardiology in review 2026. link 60 Vergara P, Migliore F, Nesti M, Pignalberi C, Conti MA, Borrello F et al.. Nationwide survey on the current clinical practice of the first atrial fibrillation episode. International journal of cardiology 2026. link 61 Al-U'datt D, Mahmoud D, Tranchant CC, Rawashdeh S, Tashtush A, Almoghrabi KS et al.. Interrelationships between diabetes and atrial fibrillation: Comparative assessment of clinical markers and possible therapeutic implications. The American journal of the medical sciences 2026. link 62 Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D et al.. Left Atrial Appendage Occlusion Versus NOACs in patients With Atrial Fibrillation: Rationale and Design of the CATALYST Trial. American heart journal 2026. link 63 Chand S, Patel J, Tripathi A, Thapa S, Frishman WH, Aronow WS. Exploring the Intricate Interplay Between Obesity and Atrial Fibrillation: Mechanisms, Management, and Clinical Implications. Cardiology in review 2026. link 64 Shen T, Li M, Zhao M, Jiang C, Wang Z, Zhao Z et al.. Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trial. Heart rhythm 2026. link 65 Melki L, Moisa S, Reinders D, Boucher S. Overcoming the Challenges of Transmural Durable Lesions With PFA-Impact of Electrode Design and Contact Assessment. Pacing and clinical electrophysiology : PACE 2026. link 66 Marion-Knudsen R, Lindberg LA, Jespersen T, Saljic A. Quantitative histologic assessment of atrial fibrillation-associated fibrosis in animal models: A systematic review. Heart rhythm 2026. link 67 Font J, Dolladille C, Legallois D, Al Khoury M, Champ-Rigot L, Chaumont C et al.. Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20years of clinical data. Archives of cardiovascular diseases 2026. link 68 Jin JF, Huang S, Feng K, Wang XY. Study on the application of serological indicators combined with ultrasonic cardiogram in predicting recurrence of radiofrequency ablation in atrial fibrillation patients. Medicine 2026. link 69 Topçuoğlu MA, Yilmaz E, Öge DD, Ceren AN, Adin RM, Arsava EM. Sarcopenia in atrial fibrillation: a prospective study. Turkish journal of medical sciences 2026. link 70 Wang SSY, Patidar D, Mallavarapu K, Luo XR, Ibakkanavar RG, Javaid MM. Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation. British journal of hospital medicine (London, England : 2005) 2026. link 71 Solak Y, Yılmaz MM, Karaarslan O, Kalçık M. Clinical implications of failed electrical cardioversion in long-standing persistent atrial fibrillation. Acta cardiologica 2026. link 72 Verma A, Birnie DH, Jiang C, Heidbüchel H, Hindricks G, Kirchhof P et al.. Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. The New England journal of medicine 2026. link 73 Pizzi C, Pagliani L, Carbonare LD, Agostoni P, Imbalzano E, Galasso G et al.. Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF. PloS one 2026. link 74 Su W, Bai R, Chierchia GB, Yap SC, Tondo C, Schilling R et al.. Best practices IV in cryoballoon ablation of atrial fibrillation: Important clinical and practical differences for new compliant and size-adjustable cryoballoon systems. Heart rhythm 2026. link 75 Kobayashi Y, Yuzawa C, Kurashina M, Shimizu Y, Sekijima Y. Transesophageal Echocardiography Can Detect Atrial Fibrillation Masked by a Pacemaker: A Case Series. Journal of clinical ultrasound : JCU 2026. link 76 Zhou W, Bozenhardt E, Alexander GE, Zierhut ML, Merali S, Ajavon-Hartmann A et al.. Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation. Clinical pharmacology and therapeutics 2026. link 77 Vrtal J, Plasek J, Vaclavik J, Dodulik J, Sipula D. Anticoagulation in device-detected atrial fibrillation: Challenges in stroke prevention and heart failure management. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2026. link 78 Rodrigo M, Ruipérez-Campillo S, Ganesan P, Feng R, Narayan SM. Impact of Catheter Configuration on the Mapping of Atrial Fibrillation. Circulation. Arrhythmia and electrophysiology 2026. link 79 Briosa E Gala A, Sharp AJ, Pope MTB, Leo M, Varini R, Paisey J et al.. Real-time smartphone alerts during atrial fibrillation episodes with implantable cardiac monitors and wearable devices: SMART-ALERT study. Heart rhythm 2026. link 80 Zappon E, Azzolin L, Gsell MAF, Thaler F, Prassl AJ, Arnold R et al.. An efficient end-to-end computational framework for the generation of ECG calibrated volumetric models of human atrial electrophysiology. Medical image analysis 2026. link 81 Koop BE, Albrecht EM, Lecy E, Kippola J. Pulsed Field Ablation in Patients With Cardiac Implantable Electric Devices: Vigilance Is Warranted. Pacing and clinical electrophysiology : PACE 2026. link 82 Askarinejad A, Bucci T, Asgharzadeh N, Amirjam Z, Tartaglia E, Rossi M et al.. Machine learning-based prediction of atrial fibrillation in patients with atrial high-rate episodes. European journal of clinical investigation 2026. link 83 Higashi EM, Neves ILI, Darrieux FCDC, Alves Dos Santos Paul M, Paiva GLA, Omori VT et al.. Proposal for a tooth extraction protocol for patients taking direct oral anticoagulants: a clinical trial. Oral surgery, oral medicine, oral pathology and oral radiology 2026. link 84 Galvain T, Hill R, Donegan S, Wilkinson R, Lip GYH, Czanner G. Efficacy and Safety of DOACs in Patients with Atrial Fibrillation and History of Falls or Risk of Falls: The Liverpool AF-Falls Project. A Systematic Review and Bayesian Network Meta-analysis. Drugs & aging 2026. link 85 Chang SN, Huang PS, Chen JJ, Chiu FC, Wang YC, Wu CK et al.. Sick sinus syndrome elevates stroke risk in patients with atrial fibrillation with low CHA2DS2-VASC score. Heart rhythm 2026. link 86 Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A et al.. Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis. Circulation. Arrhythmia and electrophysiology 2026. link 87 Baron DK, Weberndorfer V, Crijns HJGM, Hemels MEW, Tieleman RG, de Melis M et al.. Association between atherosclerosis and atrial fibrillation progression in patients with paroxysmal atrial fibrillation: Data from the RACE V study. American heart journal 2026. link 88 Tan JL, Chirinos J, Patel D, Jagasia D, Hyman MC, Guandalini GS et al.. Intracardiac echocardiography for left ventricular diastolic function assessment during atrial fibrillation ablation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2026. link 89 Barreiro Mesa L, Ruiz Ortiz M, Recio Mayoral A, Reina Moreno A, Nevado Portero J, Del Toro Esperón C et al.. Left atrial appendage closure after a hospital admission for bleeding in atrial fibrillation patients: frequency, associated factors and prognosis. Cardiovascular intervention and therapeutics 2026. link 90 Yamaguchi R, Yamamoto M, Sago M, Tsunaki T, Kagase A, Tokuda T et al.. New Measurements Using Computed Tomography Predict Success of Left Atrial Appendage Closure. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 91 Parsa S, Somani S, Rogers AJ, Hernandez-Boussard T, Jain SS, Rodriguez F. Large Language Modeling-Enabled Analysis of Atrial Fibrillation on Social Media. Journal of the American Heart Association 2026. link 92 Auf der Heiden C, Bejinariu AG, Kelm M, Spieker M, Rana O. Hemolysis after pulsed-field ablation in pulmonary vein isolation for atrial fibrillation: A prospective controlled trial. Heart rhythm 2026. link 93 de Carvalho AA, de Carvalho WA, Donato G, de Lira Sobral RF, Mariz PF, Macedo AVS et al.. Catheter ablation in patients with atrial fibrillation and cancer: a systematic review and updated meta-analysis. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2026. link 94 Mei DA, Bucci T, Romiti GF, Corica B, Shantsila A, Tse HF et al.. Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries. European journal of clinical investigation 2026. link 95 Bidaoui G, Massad C, Abi-Rached J, Abdelmaksoud A, Toraih E, Abou-Khalil M et al.. Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea. Journal of cardiovascular electrophysiology 2026. link 96 Türk UÖ, Kocabaş U, Arslan U, Akgün DE, Çoner A, Yavuz V et al.. Baseline Clinical Characteristics of Patients from the Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Türkiye (ETAF-TR) Study. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2026. link 97 Huang Y, Zhou Z, Lin Y, Zhang S, Xiong Z, Liu M et al.. Time-averaged cumulative pulse pressure in midlife and incident atrial fibrillation: the atherosclerosis risk in communities study. Journal of human hypertension 2026. link 98 Ullah W, Raine D, Debski M, Rui S, Sritharan V, Ahmed W et al.. Initial UK Experience of Focal Pulsed Field Ablation. Pacing and clinical electrophysiology : PACE 2026. link 99 Konte HC, Derviş E, Alyan Ö, Aras D. Association of MAPH and CHA₂DS₂-VASc Scores with Left Atrial Thrombus in Atrial Fibrillation Patients Undergoing Ablation: A Comparative Evaluation. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2026. link 100 Soler-Espejo E, Ramos-Bratos MP, Chen Y, González-Lozano E, Rivera-Caravaca JM, Marín F et al.. Phenotype-guided risk stratification in anticoagulated atrial fibrillation patients: Cluster analysis of the Murcia AF Project III (MAFP-III). Heart rhythm 2026. link

Original source

[1]
Postoperative Atrial Fibrillation in Patients Undergoing Non-Cardiac Surgery. — Roozbehi K, Semirani-Nezhad D, Soleimani H, Soltani P, Saeidi S, Farahvash Y et al. The American journal of cardiology (2026)
[2]
Prognostic Impact of Early Recurrence Following Pulsed Field Ablation: A Meta-Analysis. — Arevalo E, Erazo C, Serpa F, Rivera A, Kewcharoen J, Bhardwaj R et al. Journal of cardiovascular electrophysiology (2026)
[3]
Evaluating Pulsed Field Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Procedural Outcomes. — Prajapati P, Vemulapalli HS, Rodriguez-Riascos JF, Muthu P, Srivathsan K Pacing and clinical electrophysiology : PACE (2026)
[4]
Surgical ablation in non-mitral valve cardiac surgeries: a meta-analysis of early outcomes. — Barbosa GS, Katsuyama ES, Fukunaga CK, Fernandes JM, Coan ACC, Palatianos Y et al. Heart (British Cardiac Society) (2026)
[5]
Comparative Outcomes of ICE Versus TEE/Fluoroscopy Guidance Transseptal Puncture in LA Procedures: A Systematic Review and Meta-Analysis. — Abdalla AME, Durga KP, Chukka A, Kotte M, Awais M, Perveen A et al. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (2026)
[6]
Ablation of atrial fibrillation and risk of stroke: A meta-analysis. — Providencia R, Ali H, Barra S, Creta A, Kukendrarajah K, Kanagaratnam P et al. Heart rhythm (2026)
[7]
Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis. — Samaras A, Karakasis P, Feidakis A, Giannakoulas G, Fragakis N, Nielsen-Kudsk JE et al. European heart journal. Cardiovascular pharmacotherapy (2026)
[8]
Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial. — Wong CX, Cheung CC, Montenegro G, Oo HH, Peña IJ, Tang JJ et al. JAMA (2026)
[9]
Less recurrent atrial fibrillation with coffee consumption versus abstinence. — Rosenberg K The American journal of nursing (2026)
[10]
After cardioversion in AF, continued caffeinated coffee consumption vs. abstinence reduced AF or atrial flutter recurrence at 6 mo. — Agarwal A, Ezekowitz J Annals of internal medicine (2026)
[11]
In symptomatic AF, nurse-led pre-ablation lifestyle treatment reduced repeat ablations or cardioversions at 1 y. — Papakonstantinou PE, Lip GYH Annals of internal medicine (2026)
[12]
Pro- and Anti-Inflammatory Cytokines' Implication in Right Heart Disease, Arrhythmogenesis, and Atrial Fibrillation. — Khider D, Neuilly O, Hiram R Biomolecules (2026)
[13]
Guideline commentary on the ESC/EACTS 2024 guidelines for atrial fibrillation: a focus on managing AF in the older population. — Kaba RA, Rajkumar C, Mattace-Raso F Age and ageing (2026)
[14]
AF-CARE in the Elderly: Implications of the 2024 ESC Guideline on the Management of Atrial Fibrillation in Older Patients. — Wolfes J, Colla CA, Frommeyer G, Ellermann C, Eckardt L Gerontology (2026)
[15]
Comparing Guidelines for Atrial Fibrillation: Focus on Emergency Medicine. — Atzema CL, Cox JL, Cheung CC, Coll-Vinent B, Benjamin EJ, Jackevicius CA et al. Annals of emergency medicine (2026)
[16]
Pulmonary Vein Isolation: Patient Experience under Conscious Sedation versus Anaesthesia. — Maher L, McCarthy R, Helmi L, Byrne L, Kelly B, Walsh K Irish medical journal (2026)
[17]
Circular over-the-wire pulsed field ablation for atrial fibrillation: differences in outcomes between conscious sedation or general anesthesia. — Van der Graaf M, Abeln BGS, Van Dijk VF, Liebregts M, Wijffels MCEF, Balt JC et al. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2026)
[18]
Conscious Sedation Versus General Anesthesia for Percutaneous Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis. — Jain H, Passey S, Jain J, Soni K, Pushparaji B, Ahmed R et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[19]
Safety of cardiologist-only propofol sedation for elective electrical cardioversion: a retrospective observational study. — Biasin M, Lomi S, Pagani L, Noacco Y, Bonadiman L, Betta D et al. Journal of cardiovascular medicine (Hagerstown, Md.) (2026)
[20]
Remimazolam Besylate Versus Propofol for Procedural Sedation in Patients Undergoing Electrical Cardioversion: A Prospective, Noninferiority Cohort Study. — D'Andria Ursoleo J, Bottussi A, Agosta VT, Barucco G, Ripoll JG, Cinotti R et al. Journal of cardiothoracic and vascular anesthesia (2026)
[21]
Current status and associated factors of intraoperative pain during radiofrequency catheter ablation for atrial fibrillation under conscious sedation: single-center experience. — Du M, Ye L, Zhang Q, Yao X, Mi J, Li L et al. BMC cardiovascular disorders (2026)
[22]
Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trial. — Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G et al. American heart journal (2026)
[23]
Trends in Polypharmacy Among Patients With Atrial Fibrillation: A Report From the Finnish AntiCoagulation in Atrial Fibrillation Nationwide Cohort Study. — Kiuru N, Reinilä S, Langén V, Jaakkola J, Airaksinen KEJ, Halminen O et al. Journal of the American Heart Association (2026)
[24]
Corticosteroid Use and Atrial Fibrillation: Exploring Underlying Mechanisms, FAERS Disproportionality Analysis, and a Meta-Analysis of Clinical Studies. — Hardi H, Barinda AJ, Vidya AP, Utama KE, Mahata LE Cardiovascular toxicology (2026)
[25]
Burden and age-specific trends of atrial fibrillation/atrial flutter from 1990 to 2023: a growing challenge among younger and middle-aged adults. — Tan S, Zhang Z, Lin Q, Tu T, Zhu J, Zeng G et al. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2026)
[26]
Machine learning for the prediction of atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis. — Monteiro SM, Bota P, Cunha PS, Oliveira MM, Laranjo S, da Silva HP Computer methods and programs in biomedicine (2026)
[27]
Non-inferiority clinical trials: What they are and when they should be done. — Pais P The National medical journal of India (2026)
[28]
Inflammation and myocardial injury after pulmonary vein isolation with distinct pulsed field ablation modalities: Comparison with thermal ablation. — Yano M, Egami Y, Kise M, Mukai T, Kobayashi N, Sugino A et al. International journal of cardiology (2026)
[29]
The ICE-AFIB trial: A multicenter prospective investigational device exemption (IDE) trial using cryosurgical ablation for atrial fibrillation during concomitant cardiac surgery. — Ad N, Romano MA, Bolling S, Zhou Z, McCarthy P, Malaisrie C et al. The Journal of thoracic and cardiovascular surgery (2026)
[30]
Utility of Pharmacologic Conversion of Persistent Atrial Fibrillation by Amiodarone as a Predictor of Outcome After Pulmonary Vein Isolation. — Krányák D, Novák A, Pataky N, Sághy L, Vámos M, Szili-Török T et al. Journal of cardiovascular electrophysiology (2026)
[31]
Sex differences in human atrial electrophysiology: the dark side of the moon? Will engineered heart tissue help to bring light into the darkness? — Ismaili D, Im J, Schnabel RB, Eschenhagen T, Christ T Naunyn-Schmiedeberg's archives of pharmacology (2026)
[32]
Management of oral anticoagulation after pulsed field ablation for atrial fibrillation: Insights from a multicenter study. — Mohanty S, Torlapati PG, Casella M, La Fazia VM, Valeri Y, Gianni C et al. Heart rhythm (2026)
[33]
Quality of life, care needs and priorities in atrial fibrillation: the impact of number and patterns of comorbidities. — Trevisan C, Ravelli A, Rivera-Caravaca JM, Zanforlini BM, Sergi G, Dan GA et al. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2026)
[34]
Simultaneous Leadless Pacemaker Implant With Atrioventricular Node Ablation via Internal Jugular Approach. — Lee JJ, Daoud EG, Simon JW, Aasbo JD, Tomassoni GF Pacing and clinical electrophysiology : PACE (2026)
[35]
Epicardial Adipose Tissue as a Cardiometabolic Target in Atrial Fibrillation: Implications for Ablation Strategies and Emerging Metabolic Therapies. — Cacciapuoti F Medical sciences (Basel, Switzerland) (2026)
[36]
Incidence and Predictors of Hypoattenuated Thickening and Device-Related Thrombus at Three Months Postprocedural CT Assessment Following Left Atrial Appendage Occlusion With Amplatzer Devices-A Single-Center Cohort. — Guilleminot P, Richard C, Roger A, Daller M, Laurent G, Vergely C et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[37]
Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland. — Tanner H, Dernektsi C, Neugebauer F, Goulouti E, Lam A, Elchinova E et al. BMJ open (2026)
[38]
Mitochondrial NOX4 drives atrial fibrillation via redox-dependent structural remodeling and fibrosis. — Mondragon RR, Vendrov AE, Lozhkin A, Jimenez Vazquez EN, Wang S, Hayami T et al. Free radical biology & medicine (2026)
[39]
RNA sequence analysis of differentially expressed genes in left atrial appendage thrombus. — Maeda J, Furutani M, Miyauchi S, Nakashima M, Ishibashi N, Sakai T et al. Journal of thrombosis and thrombolysis (2026)
[40]
ICE-Guided Cavotricuspid Isthmus Ablation Using a Circular Multielectrode Pulsed-Field Catheter: Stepwise Strategy. — Nozoe M, Mannoji H, Ikenaga T, Yamamoto S, Miyake R, Ishikita A et al. Pacing and clinical electrophysiology : PACE (2026)
[41]
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation. — Harrington J, Reddy RK, Carnicelli A, Wilson L, Lopes RD, Gersh BJ et al. American heart journal (2026)
[42]
Prolonged P-wave duration is associated with increased left atrial volume and delayed atrial conduction assessed by electro-anatomic mapping in patients with atrial fibrillation. — Kabutoya T, Makimoto H, Anno K, Kurosu YT, Kimura Y, Okuyama T et al. Journal of electrocardiology (2026)
[43]
Effects of Atrial Fibrillation Screening According to Echocardiographic Measures of Cardiac Structure and Function: A Post Hoc Analysis of the LOOP Randomized Clinical Trial. — Olsen FJ, Diederichsen SZ, Jørgensen PG, Jensen MT, Dahl A, Landler NE et al. Journal of the American Heart Association (2026)
[44]
Risk factors of failed electrical cardioversion in patients with persistent or long-standing persistent atrial fibrillation. — Ku D, Lim HE, Park J, Kim S, Kim DK, Kim DI et al. Acta cardiologica (2026)
[45]
Targetable atrial tachycardias after artificial intelligence-guided ablation of persistent atrial fibrillation. — Deisenhofer I, Seitz J, Lotteau S, Albenque JP, Busch S, Nguyen-Tu MS et al. Heart rhythm (2026)
[46]
A single-center trial of electrographic flow mapping and concomitant voltage mapping in sinus rhythm and atrial fibrillation (FLOW EVAL-AF). — Sommer P, Castellano S, Ahapov K, Jansen MM, Mehta NK, Kong MH Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2026)
[47]
Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry. — Liu H, Bucci T, Lam SHM, Chen Y, Zhao M, Romiti GF et al. Heart rhythm (2026)
[48]
Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications. — Rankinen J, Hernesniemi J, Tynkkynen JT Heart (British Cardiac Society) (2026)
[49]
N6-methyladenosine modification of NEU1 mediated by METTL3 exacerbates angiotensin II-induced atrial fibrillation. — Zhang Z, Luo Y, Zou Q, Mo Z Cell adhesion & migration (2026)
[50]
Wide-Antral pulmonary vein isolation in patients undergoing atrial fibrillation ablation with a Single-Shot technique: rationale and design of the WIDER-PVI trial. — Cobarro L, Negreira-Caamaño M, Gómez-Burgueño L, López-Alacid I, Ramos-Jiménez J, Marco Del Castillo Á et al. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2026)
[51]
Initial Clinical Experience With a Novel 4D Intracardiac Echocardiographic Imaging and Guidance System in Catheter Ablation Procedures. — Szeplaki G, Fitzpatrick N, Laurilla K, Dudurych I, Sommerijns E, Komleva A et al. Journal of cardiovascular electrophysiology (2026)
[52]
Atrial myopathy in persistent atrial fibrillation: Three-dimensional quantification of atrial fibrosis by high-density electro-anatomic mapping and its association with arrhythmia duration. — Robledo-Nolasco R, Andrade-Cuellar EN, Solis-Gómez JC, Guillot-Castillo SY, Zamora-Diaz JJIY, Aceves-Millan R et al. Current problems in cardiology (2026)
[53]
Real-World Edoxaban Concentrations in Older Patients Receiving Reduced-Dose Regimens. — Tang SC, Lin SY, Chen CH, Liu YB, Ho LT, Kuo CH et al. Clinical pharmacology and therapeutics (2026)
[54]
Mapping the unseen: Programmed electrical stimulation to detect concealed conduction block. — Liao R, Zhang L, Knops P, Ye Z, Taverne YJHJ, Kluin J et al. Heart rhythm (2026)
[55]
Anteroposterior vs Anterolateral Shock Vectors for Atrial Fibrillation Cardioversion: Design and Rationale of the SHOCK-VECTOR Trial. — Suri RS, McIntyre WF, Belley-Cote EP, Fournier RN, Um KJ, Farkhondehpay N et al. The Canadian journal of cardiology (2026)
[56]
Questioning the role of pulmonary vein isolation in multimorbid patients: A prospective analysis in more than 1400 AF patients. — Rothe M, Boehmer AA, Schneider KY, Spork P, Wiedenmann LC, Nussbaum E et al. Heart rhythm (2026)
[57]
Determinants of quality of life in older adults with atrial fibrillation: a structural equation modeling analysis. — Qiao CY, Xu Y, Jiang R, Zhang M, Huang BJ, Ding L Frontiers in public health (2026)
[58]
Atrial fibrillation. — Lane DA, Andrade JG, Arbelo E, Boriani G, Hendriks JM, Lee SR et al. Lancet (London, England) (2026)
[59]
Optimal Timing and Duration of Beta-Blocker Therapy for Preventing Postoperative Atrial Fibrillation: A Literature Review. — Abouzid MR, Nwaukwa C Cardiology in review (2026)
[60]
Nationwide survey on the current clinical practice of the first atrial fibrillation episode. — Vergara P, Migliore F, Nesti M, Pignalberi C, Conti MA, Borrello F et al. International journal of cardiology (2026)
[61]
Interrelationships between diabetes and atrial fibrillation: Comparative assessment of clinical markers and possible therapeutic implications. — Al-U'datt D, Mahmoud D, Tranchant CC, Rawashdeh S, Tashtush A, Almoghrabi KS et al. The American journal of the medical sciences (2026)
[62]
Left Atrial Appendage Occlusion Versus NOACs in patients With Atrial Fibrillation: Rationale and Design of the CATALYST Trial. — Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D et al. American heart journal (2026)
[63]
Exploring the Intricate Interplay Between Obesity and Atrial Fibrillation: Mechanisms, Management, and Clinical Implications. — Chand S, Patel J, Tripathi A, Thapa S, Frishman WH, Aronow WS Cardiology in review (2026)
[64]
Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trial. — Shen T, Li M, Zhao M, Jiang C, Wang Z, Zhao Z et al. Heart rhythm (2026)
[65]
Overcoming the Challenges of Transmural Durable Lesions With PFA-Impact of Electrode Design and Contact Assessment. — Melki L, Moisa S, Reinders D, Boucher S Pacing and clinical electrophysiology : PACE (2026)
[66]
Quantitative histologic assessment of atrial fibrillation-associated fibrosis in animal models: A systematic review. — Marion-Knudsen R, Lindberg LA, Jespersen T, Saljic A Heart rhythm (2026)
[67]
Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20years of clinical data. — Font J, Dolladille C, Legallois D, Al Khoury M, Champ-Rigot L, Chaumont C et al. Archives of cardiovascular diseases (2026)
[68]
Study on the application of serological indicators combined with ultrasonic cardiogram in predicting recurrence of radiofrequency ablation in atrial fibrillation patients. — Jin JF, Huang S, Feng K, Wang XY Medicine (2026)
[69]
Sarcopenia in atrial fibrillation: a prospective study. — Topçuoğlu MA, Yilmaz E, Öge DD, Ceren AN, Adin RM, Arsava EM Turkish journal of medical sciences (2026)
[70]
Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation. — Wang SSY, Patidar D, Mallavarapu K, Luo XR, Ibakkanavar RG, Javaid MM British journal of hospital medicine (London, England : 2005) (2026)
[71]
Clinical implications of failed electrical cardioversion in long-standing persistent atrial fibrillation. — Solak Y, Yılmaz MM, Karaarslan O, Kalçık M Acta cardiologica (2026)
[72]
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. — Verma A, Birnie DH, Jiang C, Heidbüchel H, Hindricks G, Kirchhof P et al. The New England journal of medicine (2026)
[73]
Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF. — Pizzi C, Pagliani L, Carbonare LD, Agostoni P, Imbalzano E, Galasso G et al. PloS one (2026)
[74]
Best practices IV in cryoballoon ablation of atrial fibrillation: Important clinical and practical differences for new compliant and size-adjustable cryoballoon systems. — Su W, Bai R, Chierchia GB, Yap SC, Tondo C, Schilling R et al. Heart rhythm (2026)
[75]
Transesophageal Echocardiography Can Detect Atrial Fibrillation Masked by a Pacemaker: A Case Series. — Kobayashi Y, Yuzawa C, Kurashina M, Shimizu Y, Sekijima Y Journal of clinical ultrasound : JCU (2026)
[76]
Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation. — Zhou W, Bozenhardt E, Alexander GE, Zierhut ML, Merali S, Ajavon-Hartmann A et al. Clinical pharmacology and therapeutics (2026)
[77]
Anticoagulation in device-detected atrial fibrillation: Challenges in stroke prevention and heart failure management. — Vrtal J, Plasek J, Vaclavik J, Dodulik J, Sipula D Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia (2026)
[78]
Impact of Catheter Configuration on the Mapping of Atrial Fibrillation. — Rodrigo M, Ruipérez-Campillo S, Ganesan P, Feng R, Narayan SM Circulation. Arrhythmia and electrophysiology (2026)
[79]
Real-time smartphone alerts during atrial fibrillation episodes with implantable cardiac monitors and wearable devices: SMART-ALERT study. — Briosa E Gala A, Sharp AJ, Pope MTB, Leo M, Varini R, Paisey J et al. Heart rhythm (2026)
[80]
An efficient end-to-end computational framework for the generation of ECG calibrated volumetric models of human atrial electrophysiology. — Zappon E, Azzolin L, Gsell MAF, Thaler F, Prassl AJ, Arnold R et al. Medical image analysis (2026)
[81]
Pulsed Field Ablation in Patients With Cardiac Implantable Electric Devices: Vigilance Is Warranted. — Koop BE, Albrecht EM, Lecy E, Kippola J Pacing and clinical electrophysiology : PACE (2026)
[82]
Machine learning-based prediction of atrial fibrillation in patients with atrial high-rate episodes. — Askarinejad A, Bucci T, Asgharzadeh N, Amirjam Z, Tartaglia E, Rossi M et al. European journal of clinical investigation (2026)
[83]
Proposal for a tooth extraction protocol for patients taking direct oral anticoagulants: a clinical trial. — Higashi EM, Neves ILI, Darrieux FCDC, Alves Dos Santos Paul M, Paiva GLA, Omori VT et al. Oral surgery, oral medicine, oral pathology and oral radiology (2026)
[84]
Efficacy and Safety of DOACs in Patients with Atrial Fibrillation and History of Falls or Risk of Falls: The Liverpool AF-Falls Project. A Systematic Review and Bayesian Network Meta-analysis. — Galvain T, Hill R, Donegan S, Wilkinson R, Lip GYH, Czanner G Drugs & aging (2026)
[85]
Sick sinus syndrome elevates stroke risk in patients with atrial fibrillation with low CHA2DS2-VASC score. — Chang SN, Huang PS, Chen JJ, Chiu FC, Wang YC, Wu CK et al. Heart rhythm (2026)
[86]
Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis. — Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A et al. Circulation. Arrhythmia and electrophysiology (2026)
[87]
Association between atherosclerosis and atrial fibrillation progression in patients with paroxysmal atrial fibrillation: Data from the RACE V study. — Baron DK, Weberndorfer V, Crijns HJGM, Hemels MEW, Tieleman RG, de Melis M et al. American heart journal (2026)
[88]
Intracardiac echocardiography for left ventricular diastolic function assessment during atrial fibrillation ablation. — Tan JL, Chirinos J, Patel D, Jagasia D, Hyman MC, Guandalini GS et al. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2026)
[89]
Left atrial appendage closure after a hospital admission for bleeding in atrial fibrillation patients: frequency, associated factors and prognosis. — Barreiro Mesa L, Ruiz Ortiz M, Recio Mayoral A, Reina Moreno A, Nevado Portero J, Del Toro Esperón C et al. Cardiovascular intervention and therapeutics (2026)
[90]
New Measurements Using Computed Tomography Predict Success of Left Atrial Appendage Closure. — Yamaguchi R, Yamamoto M, Sago M, Tsunaki T, Kagase A, Tokuda T et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[91]
Large Language Modeling-Enabled Analysis of Atrial Fibrillation on Social Media. — Parsa S, Somani S, Rogers AJ, Hernandez-Boussard T, Jain SS, Rodriguez F Journal of the American Heart Association (2026)
[92]
Hemolysis after pulsed-field ablation in pulmonary vein isolation for atrial fibrillation: A prospective controlled trial. — Auf der Heiden C, Bejinariu AG, Kelm M, Spieker M, Rana O Heart rhythm (2026)
[93]
Catheter ablation in patients with atrial fibrillation and cancer: a systematic review and updated meta-analysis. — de Carvalho AA, de Carvalho WA, Donato G, de Lira Sobral RF, Mariz PF, Macedo AVS et al. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2026)
[94]
Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries. — Mei DA, Bucci T, Romiti GF, Corica B, Shantsila A, Tse HF et al. European journal of clinical investigation (2026)
[95]
Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea. — Bidaoui G, Massad C, Abi-Rached J, Abdelmaksoud A, Toraih E, Abou-Khalil M et al. Journal of cardiovascular electrophysiology (2026)
[96]
Baseline Clinical Characteristics of Patients from the Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Türkiye (ETAF-TR) Study. — Türk UÖ, Kocabaş U, Arslan U, Akgün DE, Çoner A, Yavuz V et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir (2026)
[97]
Time-averaged cumulative pulse pressure in midlife and incident atrial fibrillation: the atherosclerosis risk in communities study. — Huang Y, Zhou Z, Lin Y, Zhang S, Xiong Z, Liu M et al. Journal of human hypertension (2026)
[98]
Initial UK Experience of Focal Pulsed Field Ablation. — Ullah W, Raine D, Debski M, Rui S, Sritharan V, Ahmed W et al. Pacing and clinical electrophysiology : PACE (2026)
[99]
Association of MAPH and CHA₂DS₂-VASc Scores with Left Atrial Thrombus in Atrial Fibrillation Patients Undergoing Ablation: A Comparative Evaluation. — Konte HC, Derviş E, Alyan Ö, Aras D Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir (2026)
[100]
Phenotype-guided risk stratification in anticoagulated atrial fibrillation patients: Cluster analysis of the Murcia AF Project III (MAFP-III). — Soler-Espejo E, Ramos-Bratos MP, Chen Y, González-Lozano E, Rivera-Caravaca JM, Marín F et al. Heart rhythm (2026)

Share:Twitter Reddit LinkedIn